Loading…
Lobbying Spend
—
Filings
87
Firms Hired
3
Active Period
2013–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day".
2026 · third_quarter · Firm: PORTERFIELD, FETTIG & SEARS, LLC
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: H.Res.1270
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: S.1330
A resolution designating July 15, 2026, as "Glioblastoma Awareness Day".
2026 · third_quarter · Firm: PORTERFIELD, FETTIG & SEARS, LLC
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: S.Res.786
Mikaela Naylon Give Kids a Chance Act
2026 · third_quarter · Firm: BRACEWELL LLP
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330), Mikaela Naylon Give Kids a Chance Act (H.R.1262)
Client expense: — · Firm income: $20,000
Matched citations: H.R.1262
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330), Mikaela Naylon Give Kids a Chance Act (H.R.1262)
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330), Mikaela Naylon Give Kids a Chance Act (H.R.1262)
Client expense: — · Firm income: $20,000
Matched citations: S.1330
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day".
2026 · second_quarter · Firm: PORTERFIELD, FETTIG & SEARS, LLC
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: H.Res.1270
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: S.1330
A resolution designating July 15, 2026, as "Glioblastoma Awareness Day".
2026 · second_quarter · Firm: PORTERFIELD, FETTIG & SEARS, LLC
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."
Client expense: — · Firm income: $20,000
Matched citations: S.Res.786
Mikaela Naylon Give Kids a Chance Act
2026 · second_quarter · Firm: BRACEWELL LLP
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330), Mikaela Naylon Give Kids a Chance Act (H.R.1262)
Client expense: — · Firm income: $20,000
Matched citations: H.R.1262
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330), Mikaela Naylon Give Kids a Chance Act (H.R.1262)
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330), Mikaela Naylon Give Kids a Chance Act (H.R.1262)
Client expense: — · Firm income: $20,000
Matched citations: S.1330
Mikaela Naylon Give Kids a Chance Act
2026 · first_quarter · Firm: PORTERFIELD, FETTIG & SEARS, LLC
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.R.1262, Give Kids a Chance Act; H.R.1509, Accelerating Kids Access to Care Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.1262
Accelerating Kids’ Access to Care Act of 2025
2026 · first_quarter · Firm: PORTERFIELD, FETTIG & SEARS, LLC
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.R.1262, Give Kids a Chance Act; H.R.1509, Accelerating Kids Access to Care Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.1509
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.R.1262, Give Kids a Chance Act; H.R.1509, Accelerating Kids Access to Care Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.R.1262, Give Kids a Chance Act; H.R.1509, Accelerating Kids Access to Care Act.
Client expense: — · Firm income: $20,000
Matched citations: S.1330
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330).
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330).
Client expense: — · Firm income: $20,000
Matched citations: S.1330
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330).
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
Issues related to the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330).
Client expense: — · Firm income: $20,000
Matched citations: S.1330
Mikaela Naylon Give Kids a Chance Act
2025 · fourth_quarter · Firm: PORTERFIELD, FETTIG & SEARS, LLC
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.R.1262, Give Kids a Chance Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.1262
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.R.1262, Give Kids a Chance Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2767
General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.R.1262, Give Kids a Chance Act.
Client expense: — · Firm income: $20,000
Matched citations: S.1330
Source: Senate LDA